Compare MDBH & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDBH | HBIO |
|---|---|---|
| Founded | 1997 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.7M | 33.8M |
| IPO Year | 2023 | 2000 |
| Metric | MDBH | HBIO |
|---|---|---|
| Price | $3.27 | $0.58 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 12.2K | ★ 326.3K |
| Earning Date | 11-13-2025 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | $1,250,398.00 | ★ $87,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.80 |
| P/E Ratio | $4.38 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.11 | $0.28 |
| 52 Week High | $7.98 | $1.84 |
| Indicator | MDBH | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 42.26 | 39.78 |
| Support Level | $3.21 | $0.57 |
| Resistance Level | $3.48 | $0.63 |
| Average True Range (ATR) | 0.16 | 0.04 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 9.93 | 20.71 |
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.